Page 3 - Joshuat Brumm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Joshuat brumm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Joshuat Brumm Today - Breaking & Trending Today

Dyne Therapeutics, Inc. (NYSE:DYN) CEO Sells $4,045,101.36 in Stock

Dyne Therapeutics, Inc. (NYSE:DYN) CEO Sells $4,045,101.36 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Joshuat Brumm , Zurcher Kantonalbank Zurich Cantonalbank , Raymond James , Dyne Therapeutics Company Profile , Dyne Therapeutics Inc , Ameritas Investment Partners Inc , Allspring Global Investments Holdings , Sphera Funds Management , Royal Bank , Securities Exchange Commission , Dyne Therapeutics , Get Free Report , Exchange Commission , Investment Partners , Kantonalbank Zurich Cantonalbank , Global Investments Holdings , Dyne Therapeutics Daily ,

Dyne Therapeutics (NYSE:DYN) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Dyne Therapeutics (NYSE:DYN – Free Report) in a report released on Thursday morning. The firm issued a sell rating on the stock. Several other brokerages also recently weighed in on DYN. Chardan Capital restated a buy rating and set a $20.00 price objective on shares of Dyne Therapeutics in […] ....

United States , Joshuat Brumm , Sg Americas Securities , Dyne Therapeutics Inc , Deutsche Bank , Principal Financial Group Inc , Ameritas Investment Partners Inc , Swiss National Bank , Jpmorgan Chase Co , Securities Exchange Commission , Dyne Therapeutics Company Profile , Dyne Therapeutics , Free Report , Moderate Buy , Exchange Commission , Financial Group , Investment Partners , National Bank , Get Free Report , Dyne Therapeutics Daily , Nyse Dyn , Initiated Coverage , Stocknews Com ,

Dyne Therapeutics, Inc. (NYSE:DYN) Receives Average Rating of "Buy" from Analysts

Dyne Therapeutics, Inc. (NYSE:DYN) Receives Average Rating of "Buy" from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Joshuat Brumm , Richard William Scalzo , Securities Exchange Commission , Jpmorgan Chase Co , Dyne Therapeutics Inc , Wells Fargo Company , Dyne Therapeutics Company Profile , Nuveen Asset Management , Goldman Sachs Group Inc , Dyne Therapeutics , Get Free Report , Exchange Commission , Asset Management , Goldman Sachs Group , Sachs Group , Therapeutics Stock Down , Get Free , Dyne Therapeutics Daily ,

Dyne Therapeutics (NYSE:DYN) Given New $22.00 Price Target at JPMorgan Chase & Co.

Dyne Therapeutics (NYSE:DYN – Free Report) had its price target lifted by JPMorgan Chase & Co. from $20.00 to $22.00 in a report released on Wednesday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. Several other brokerages have also weighed in on DYN. Chardan Capital reiterated a buy rating […] ....

United States , Joshuat Brumm , Richard William Scalzo , Sphera Funds Management , Ameritas Investment Partners Inc , Dyne Therapeutics Company Profile , Dyne Therapeutics Inc , Allspring Global Investments Holdings , Group Plc , Jpmorgan Chase Co , Dyne Therapeutics , Free Report , Moderate Buy , Get Free Report , Investment Partners , Global Investments Holdings , Funds Management , General Group Plc , Dyne Therapeutics Daily , Nyse Dyn , Boost Price Target , Jpmorgan Chase Co ,

Dyne Therapeutics (NYSE:DYN) Given New $22.00 Price Target at JPMorgan Chase & Co.

Dyne Therapeutics (NYSE:DYN) Given New $22.00 Price Target at JPMorgan Chase & Co.
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Joshuat Brumm , Atlas Venture Life Science Advisors , Dyne Therapeutics Company Profile , Blackrock Inc , Dyne Therapeutics Inc , Jpmorgan Chase Co , Vr Adviser , Dyne Therapeutics , Free Report , Moderate Buy , Get Free Report , Venture Life Science Advisors , Dyne Therapeutics Daily ,